AB
KLDO

Amalgamated Bank’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Amalgamated Bank’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,266
Closed -$5K – 3337
2022
Q1 		$5K Buy
+3,266
New +$5.83K ﹤0.01% 3032

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Amalgamated Bank's KLDO Position: Q2 2022 in Review

Amalgamated Bank sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 3,266 shares — an estimated $5K sold.

Amalgamated Bank first reported a position in KLDO in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Amalgamated Bank reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 3,266 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $5K.
  • Amalgamated Bank first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Kaleido Biosciences, Inc. Common Stock position peaked at $5K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.